Clinical Trial Update: Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma [Phase 2]

View source ↗

Summary

A multicenter Phase 2 trial evaluating a tailored strategy for locally advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Locally Advanced Malignant Neoplasm, Rectal Carcinoma | Phase 2 | Status: COMPLETED